5-{[(3R,4R)-1-(4-chloro-2,6-difluorophenyl)-3,4-dihydroxypiperidin-4-yl]methoxy}-8-fluoro-3,4-dihydroquinolin-2(1H)-one | |
---|---|
Trade Name | |
Orphan Indication | Active tuberculosis |
USA Market Approval | USA |
USA Designation Date | 2016-12-05 00:00:00 |
Sponsor | Otsuka Pharmaceutical Company, Ltd;2440 Research Blvd;Rockville, Maryland, 20850 |